中国医药科学Issue(22)：165-167,3.
吸入糖皮质激素联合茶碱与联合长效β2受体激动剂治疗哮喘的临床对照研究
The clinical control study of inhaled corticosteroid plus theophylline and combined with long-lasting β2 agonists for asthma
戚宇飞 1王克成1
作者信息
- 1. 乌鲁木齐市友谊医院呼吸科，新疆乌鲁木齐830001
- 折叠
摘要
Abstract
Objective To explore the clinical control study of inhaled corticosteroid plus theophylline and combined with long-lasting β2 agonists for asthma.Methods 115 patients with asthma from October 2014 to December 2013 in our hospital were randomly divided into observation group (ICS+LABA) 58 cases and control group (ICS+theophylline) 57 cases. The clinical effect of the two groups of patients, the changes in the lung function and the adverse reactions of the two groups before and after the treatment were all observed and compared. ResultsThe total effective of the observation group was 94.83%,significantly higher than the control group of 84.21%(P<0.05). The two groups of patients after treatment FEV1,FVC,VC,PEF and other indicators were significantly higher than before treatment, the observation group were higher than those in the control group after treatment(P<0.05).The incidence of adverse reactions in the observation group was 10.34%,which was significantly lower than that in the control group(28.06%)(P<0.05).Conclusion Inhaled corticosteroid combined with long-lasting β2 agonists for asthma clinical efficacy can significantly reduce adverse reactions, it is worthy of clinical application.关键词
茶碱/长效β2受体激动剂/吸入糖皮质激素/哮喘Key words
Theophylline/Long-lasting β2 agonists/Inhaled corticosteroid/Asthma分类
医药卫生引用本文复制引用
戚宇飞,王克成..吸入糖皮质激素联合茶碱与联合长效β2受体激动剂治疗哮喘的临床对照研究[J].中国医药科学,2015,(22):165-167,3.
